Weight-loss drugs could cause ‘more harm than good
The co-founder of Regeneron has cautioned that blockbuster weight reduction medications could cause "more harm than good" except if the quick muscle misfortune related to the medicines is addressed, as the US biotech pushes ahead with preliminaries of muscle-safeguarding prescriptions. Clinical examinations recommend that patients treated with the new class of weight reduction drugs, known as GLP-1s, lose muscle at far quicker rates than individuals getting thinner from diet or exercise, presenting them to medical conditions, said George Yancopoulos, who additionally fills in as Regeneron's chief scientific officer. For the two in each five patients who discountinue the medicines in no less than a year, as per a 2024 JAMA study, this implies that they are probably going to bounce back to their unique load with less muscle and a higher muscle versus fat ratio, "making an already difficult situation even worse", said Yancopoulos. "I truly do feel that the G...